Abstract
New Zealand (NZ) has a diverse mix of ethnicities including 16% indigenous Māori, 8% Pacific peoples and 70% Europeans [1]. Māori have lower prostate cancer incidence but significantly higher mortality than non-Māori men [2]. These statistics are comparable for the indigenous people of other countries such as African-American men in the US [3] and Aboriginal men in Australia [4]. Possible explanations for the higher mortality rate for indigenous people are the disease stage at diagnosis, lower health care utilization, worse access to advanced treatment facilities and a higher number of comorbidities [5].
© 2023 IEEE
PDF ArticleMore Like This
Suse J. van Breugel, Liam Quinn, Hannah Holtkamp, Ariane Araquel-Lacamiento, Satya Amirapu, Komal K. Srinivasa, Irene Low, Mary L. Christie, Michel K. Nieuwoudt, Morgan R. Pokorny, Ramya Nagarajan, M. Cather Simpson, Kamran Zargar-Shoshtari, and Claude Aguergaray
TM2B.4 Clinical and Translational Biophotonics (Translational) 2022
S.J. van Breugel, I. Low, M.L. Christie, M.R. Pokorny, H.U. Holtkamp, M.K. Nieuwoudt, M.C. Simpson, K. Zargar-Shoshtari, and C. Aguergaray
cl_p_2 The European Conference on Lasers and Electro-Optics (CLEO/Europe) 2023
Siddra Maryam, M Daniyal Ghauri, Edward Fahy, Sanathana Konugolu Venkata Sekar, Marcelo Saito Nogueira, Huihui Lu, Alida Russo, Ray Burke, Linda Feeley, Patrick Sheahan, Richeal Ni Riordain, Stefan Andersson-Engels, Kiang Wei Kho, and Rekha Gautam
126270B European Conference on Biomedical Optics (ECBO) 2023